Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP)’s traded shares stood at 0.46 million during the last session, with the company’s beta value hitting 2.23. At the close
In recent trading session, Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) saw 0.57 million shares changing hands at last check today with its beta currently measuring 2.23.
In recent trading session, Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) saw 0.49 million shares changing hands at last check today with its beta currently measuring 2.25.
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne